BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 17855351)

  • 1. Glycogen synthase kinase-3alpha reduces cardiac growth and pressure overload-induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases.
    Zhai P; Gao S; Holle E; Yu X; Yatani A; Wagner T; Sadoshima J
    J Biol Chem; 2007 Nov; 282(45):33181-91. PubMed ID: 17855351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutively active MEK1 rescues cardiac dysfunction caused by overexpressed GSK-3α during aging and hemodynamic pressure overload.
    Maejima Y; Galeotti J; Molkentin JD; Sadoshima J; Zhai P
    Am J Physiol Heart Circ Physiol; 2012 Oct; 303(8):H979-88. PubMed ID: 22904158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct roles of GSK-3alpha and GSK-3beta phosphorylation in the heart under pressure overload.
    Matsuda T; Zhai P; Maejima Y; Hong C; Gao S; Tian B; Goto K; Takagi H; Tamamori-Adachi M; Kitajima S; Sadoshima J
    Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20900-5. PubMed ID: 19106302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of glycogen synthase kinase 3beta during heart failure is protective.
    Hirotani S; Zhai P; Tomita H; Galeotti J; Marquez JP; Gao S; Hong C; Yatani A; Avila J; Sadoshima J
    Circ Res; 2007 Nov; 101(11):1164-74. PubMed ID: 17901358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive glycogen synthase kinase-3alpha/beta activity protects against chronic beta-adrenergic remodelling of the heart.
    Webb IG; Nishino Y; Clark JE; Murdoch C; Walker SJ; Makowski MR; Botnar RM; Redwood SR; Shah AM; Marber MS
    Cardiovasc Res; 2010 Aug; 87(3):494-503. PubMed ID: 20299330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast GSK-3α Promotes Fibrosis via RAF-MEK-ERK Pathway in the Injured Heart.
    Umbarkar P; Tousif S; Singh AP; Anderson JC; Zhang Q; Tallquist MD; Woodgett J; Lal H
    Circ Res; 2022 Sep; 131(7):620-636. PubMed ID: 36052698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiomyocyte-GSK-3α promotes mPTP opening and heart failure in mice with chronic pressure overload.
    Ahmad F; Singh AP; Tomar D; Rahmani M; Zhang Q; Woodgett JR; Tilley DG; Lal H; Force T
    J Mol Cell Cardiol; 2019 May; 130():65-75. PubMed ID: 30928428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase C regulates human pluripotent stem cell self-renewal.
    Kinehara M; Kawamura S; Tateyama D; Suga M; Matsumura H; Mimura S; Hirayama N; Hirata M; Uchio-Yamada K; Kohara A; Yanagihara K; Furue MK
    PLoS One; 2013; 8(1):e54122. PubMed ID: 23349801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3beta activation.
    Li HJ; Yin H; Yao YY; Shen B; Bader M; Chao L; Chao J
    Cardiovasc Res; 2007 Jan; 73(1):130-42. PubMed ID: 17137568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinase.
    Wang Q; Zhou Y; Wang X; Evers BM
    Oncogene; 2006 Jan; 25(1):43-50. PubMed ID: 16278684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy.
    Hardt SE; Tomita H; Katus HA; Sadoshima J
    Circ Res; 2004 Apr; 94(7):926-35. PubMed ID: 15001529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
    Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
    Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen synthase kinase-3beta plays a pro-apoptotic role in beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes: Role of beta1 integrins.
    Menon B; Johnson JN; Ross RS; Singh M; Singh K
    J Mol Cell Cardiol; 2007 Mar; 42(3):653-61. PubMed ID: 17292911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2,5-Dimethylcelecoxib prevents pressure-induced left ventricular remodeling through GSK-3 activation.
    Fujita A; Takahashi-Yanaga F; Morimoto S; Yoshihara T; Arioka M; Igawa K; Tomooka K; Hoka S; Sasaguri T
    Hypertens Res; 2017 Feb; 40(2):130-139. PubMed ID: 27628899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17/ACE2 and GSK-3β/β-catenin pathways.
    Zhai CG; Xu YY; Tie YY; Zhang Y; Chen WQ; Ji XP; Mao Y; Qiao L; Cheng J; Xu QB; Zhang C
    J Mol Cell Cardiol; 2018 Jan; 114():243-252. PubMed ID: 29196099
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Matsuno M; Yokoe S; Nagatsuka T; Morihara H; Moriwaki K; Asahi M
    Front Endocrinol (Lausanne); 2023; 14():1122125. PubMed ID: 37033243
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation of glycogen synthase kinase-3 by thymosin beta-4 is associated with gastric cancer cell migration.
    Ryu YK; Lee YS; Lee GH; Song KS; Kim YS; Moon EY
    Int J Cancer; 2012 Nov; 131(9):2067-77. PubMed ID: 22328534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapamycin attenuates load-induced cardiac hypertrophy in mice.
    Shioi T; McMullen JR; Tarnavski O; Converso K; Sherwood MC; Manning WJ; Izumo S
    Circulation; 2003 Apr; 107(12):1664-70. PubMed ID: 12668503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aliskiren ameliorates pressure overload-induced heart hypertrophy and fibrosis in mice.
    Weng LQ; Zhang WB; Ye Y; Yin PP; Yuan J; Wang XX; Kang L; Jiang SS; You JY; Wu J; Gong H; Ge JB; Zou YZ
    Acta Pharmacol Sin; 2014 Aug; 35(8):1005-14. PubMed ID: 24998254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
    Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.